Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 19, 2024 11:14am
RE:RE:RE:RE:RE:New Corporate Presentation
Sorry , should have wrote ''the CEO.CA' post or forum in my previous pot...
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 19, 2024 11:13am
RE:RE:RE:RE:New Corporate Presentation
The CEO post is okay. The only point mentioned in there that's worth discussing is the upcoming financing. 1. Will they issuing shares? How many (dilution)? At what price? Are they going to
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Sep 19, 2024 12:40am
RE:RE:RE:New Corporate Presentation
Read the posts on ceo.ca because there are a few important items tht you didn't list.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Sep 18, 2024 8:36pm
Revised September Presentation
They made a small change to their timeline on slide #16...everything is now due in Q4/24 or H1/25. I like the change they made, setting up realistic expectations/goals and then meeting the
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 18, 2024 3:23pm
RE:RE:New Corporate Presentation
Only 'negative' is that they are looking at some 'financing' in Q3/24 which means very soon... This was expected considering the expenses level vs actual revenue -- see previous posts
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 18, 2024 2:49pm
RE:New Corporate Presentation
This new presentation is refreshing to see, here's why; 1. They are focusing on Revyve; 2. They are providing 'sales guidance or forecast' for Revyve (this is a first in their case); 3
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Sep 18, 2024 2:34pm
New Corporate Presentation
I didn't look at it (yet) but here's a link to the latest company presentation; Kane - September 2024 Presentation GLTA!
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 12, 2024 9:22am
RE:New Press Release - Kane Biotech Announces Exercise of Warrants
500K in the bank account, that should help short-term. Here's an excerpt of their last financial report. Please note the expiry date for both sets of warrants....; ''Warrants: - During
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2024 8:30am
New Press Release - Kane Biotech Announces Exercise of Warrants
WINNIPEG, Manitoba, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the exercise of an aggregate of 5 million warrants at an exercise price of $0.10 per common share for total proceeds of $500,000. “The shares are being held...
read article.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 11, 2024 4:10pm
RE:RE:RE:RE:RE:RE:Technical analysis
Yup, the DispersinB approval process will take years to go through. This is why expanding the Revyve line of product makes a lot of sense financially since it coul help cover up for some cost
...more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Sep 11, 2024 3:24pm
RE:RE:RE:RE:RE:Technical analysis
There is no way to be conservative and somewhat accurate when you're dealing with the FDA because you have zero idea how long they will dither. For example, the Revyve product approval has no
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 11, 2024 2:26pm
RE:New hire...
Here's some info from LinkedIN; Marie-Pierre Maltais Relation de 3e niveau Canadian Business Development Manager - Kane Biotech Inc. Marie-Pierre
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 11, 2024 2:20pm
RE:RE:RE:RE:Technical analysis
I understand KevinOleary. FDA dealys are common but it's been happening with the almost every aspects of their business in the past -- for example, look at the acne trial with UofMiami...it's
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Sep 11, 2024 2:13pm
New hire...
KNE just hired a Sales Director for Canada...saw that on LinkedIN. She doesn't have much expertise in sales based on her LinkedIN page but, let's give her some times and wil see by ourself
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >